Microtrader, I'm with you. At the moment, ADO can't tell other companies that they're having M&G pushed through FDA approval for a particular use because if they did then they'd have to announce it to the entire market.
It's good not to be announcement happy, but waiting for FDA approval because that's what the other bio company would want.... I'm not sold on it.
One must also remember that, as a matter of courtesy, no company would ever say an outright 'No' - they'd say something like 'it is not appropriate at present for xxxx reasons', allowing ADO to declare that no company has said 'No'.
Makes me wonder how many companies are actively testing M&G, with actively being the key word......
And this is why it's fun investing in biotech.
Add to My Watchlist
What is My Watchlist?
